Nasal spray for flu prevention shows promising trial results
February 5, 2026
Researchers have developed a nasal spray for flu prevention that has shown promising results in preliminary human trials.
Researchers have developed a nasal spray for flu prevention that has shown promising results in preliminary human trials.
Dexcom (NSDQ:DXCM) announced today that it plans to launch an advanced AI-enabled enhancement to its Stelo over-the-counter CGM.
Testing menstrual blood for human papillomavirus (HPV) could be a “robust alternative or replacement” for current cervical cancer screening by a clinician.
A pioneering study marks a major step toward eliminating the need for daily insulin injections for people with diabetes.
An international research team with strong participation from DTU has developed a new biotechnological platform that makes it possible to test and understand advanced cancer treatments much faster and cheaper than before
A patient with complete blindness caused by irreversible optic nerve damage partially recovered natural vision after participating in a clinical trial of electrical stimulation of the visual cortex conducted by researchers.
Two models more accurately replicate the physiology of the liver, offering a new way to test treatments for fat buildup.
Quest expects the new blood test will support response monitoring in clinical trials.
RevealDX’s software analyses CT scans and assigns lung nodules with a Malignancy Similarity Index score to aid in lung cancer diagnosis.
Medtronic (NYSE: MDT)+
today announced three U.S. milestones expanding access to its MiniMed 780G automated insulin delivery system.